MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Willow Biosciences Inc (OP: CANSF )

0.0696 UNCHANGED
Streaming Delayed Price Updated: 10:13 AM EDT, Sep 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0696
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0696
Today's Range 0.0696 - 0.0696
52wk Range 0.0500 - 0.1050
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CBG Producer Willow Biosciences Reports Record Q2 Revenue, Enters Major Pharma Deal Slated To Be Key Driver Of Growth
Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) reported on Monday its financial and operating results for the three months ended June 30, 2024, reporting significantly higher revenue and reduced... 
Via Benzinga
CBG Producer Willow Biosciences Announces Record 43% Revenue Increase And Strategic Moves Ahead
Willow Biosciences Inc., (OTC: CANSF) a frontrunner in biotech innovations for sustainable ingredient production, reported its financial and operational results Tuesday morning for the fourth quarter... 
Via Benzinga

Performance

YTD
-8.18%
-8.18%
1 Month
+9.95%
+9.95%
3 Month
-5.05%
-5.05%
6 Month
+2.81%
+2.81%
1 Year
+0.87%
+0.87%

More News

Read More
Company Exploring CBG Production Signals New Era Of Commercial Success In Synthetic Biology
Via Benzinga
This Precision-Fermentation Company Achieves Q3 Record Revenue And Strategic Milestones In Business Expansion
Via Benzinga
Aurora Cannabis And Willow Biosciences Resolve Patent Clash
Via Benzinga
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property
Cannabis Stock Gainers And Losers From August 25, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For August 22, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For August 18, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Willow Biosciences Q1 FY23 Revenue Grows To $203K, Still In Development Stage And On 'A Solid Trajectory'
Via Benzinga
Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Keeping Up With Cannabis: Key Industry And Executive Changes You Should Know About
Via Benzinga
Willow Biosciences Touts Strong Q3 Results, Continues Its Focus On Biosynthetically Produced Cannabinoids
Via Benzinga
Cannabis Stock Gainers And Losers From August 16, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Week In Cannabis: An Earnings Avalanche, Biden's Clemency Plans, Cuomo's Resignation And More
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For August 15, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Willow Biosciences Announces Q2 2021 Results, Agrees To Supply Cellular Goods With CBG
Via Benzinga
Cannabis Stock Gainers And Losers From August 11, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For August 9, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For August 2, 2023
Via Benzinga
Marijuana Stock Movers For August 1, 2023
Via Benzinga
Cannabis Stock Gainers And Losers From July 28, 2023
Via Benzinga
Cannabis Stock Movers For July 20, 2023
Via Benzinga
Cannabis Stock Movers For July 19, 2023
Via Benzinga
The Week In Cannabis: Stocks Down, Republican Legalization Bill, Germany, Uruguay, Earnings, New ETF And More
Via Benzinga
Topics Cannabis
Exposures Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story